Andrew Thorburn, University of Colorado Anschutz Medical Campus (IMAGE)
Caption
The lab of Andrew Thorburn, PhD, shows that inhibiting FOXO3a may increase the success of anti-cancer drugs that target autophagy.
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content